DXCM Dexcom
$83.39 -4.04%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-4.04%
YTD
+26.30%
P/E
32.37
P/B
9.43
ROE
36.2%
Div yield
—
Beta
0.64
Market cap
$32.4B
RSI (14)
39
Next earnings
Oct 22, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$86.28
Close
$83.39
VWAP (n/a)
—
Day high
$86.75
Day low
$82.86
Volume
3.6M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Dexcom U Enters Season 5 With a Record Roster and Evidence That Diabetes Stigma Among Young Athletes Is Fading
Yahoo Finance · Oct 6
DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care
Yahoo Finance · Oct 2
This Stock Could Be the Big Winner Out of Oura’s IPO
Yahoo Finance · Sep 28
Dexcom Publishes New Report During EASD 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care
Yahoo Finance · Sep 28
Is DexCom (DXCM) Cheap After Its Leadership Reshuffle Or Already Fairly Priced?
Yahoo Finance · Sep 24
DexCom (DXCM) Promotes Former CFO Jereme Sylvain To Chief Operating Officer
Yahoo Finance · Sep 23
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Sep 14, 2026 View → 8-K Sep 10, 2026 View → 10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View → 8-K May 28, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell DXCM. Try it in the Lab to size a position and see the risk.